Lumipulse G β-Amyloid Ratio Test for the Diagnosis of Alzheimer Disease

被引:0
|
作者
Lau, Kyle [1 ]
Lin, Kenneth W. [1 ]
机构
[1] Lancaster Gen Hosp, Family Med Residency, Lancaster, PA 17602 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:550 / 551
页数:2
相关论文
共 50 条
  • [1] Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
    Alcolea, Daniel
    Pegueroles, Jordi
    Munoz, Laia
    Camacho, Valle
    Lopez-Mora, Diego
    Fernandez-Leon, Alejandro
    Le Bastard, Nathalie
    Huyck, Els
    Nadal, Alicia
    Olmedo, Veronica
    Sampedro, Frederic
    Montal, Victor
    Vilaplana, Eduard
    Clarimon, Jordi
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (09): : 1815 - 1824
  • [2] Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease
    Leitao, Maria Joao
    Silva-Spinola, Anuschka
    Santana, Isabel
    Olmedo, Veronica
    Nadal, Alicia
    Le Bastard, Nathalie
    Baldeiras, Ines
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)
  • [3] Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
    Maria João Leitão
    Anuschka Silva-Spínola
    Isabel Santana
    Veronica Olmedo
    Alicia Nadal
    Nathalie Le Bastard
    Inês Baldeiras
    [J]. Alzheimer's Research & Therapy, 11
  • [4] Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
    Oskar Hansson
    Sylvain Lehmann
    Markus Otto
    Henrik Zetterberg
    Piotr Lewczuk
    [J]. Alzheimer's Research & Therapy, 11
  • [5] Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease
    Hansson, Oskar
    Lehmann, Sylvain
    Otto, Markus
    Zetterberg, Henrik
    Lewczuk, Piotr
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (1) : 1 - 15
  • [6] Discordant Amyloid Status Diagnosis in Alzheimer's Disease
    Garcia-Valles, Lorena
    Pena-Bautista, Carmen
    Alvarez-Sanchez, Lourdes
    Ferrer-Cairols, Ines
    Baquero, Miguel
    Chafer-Pericas, Consuelo
    [J]. BIOMEDICINES, 2022, 10 (11)
  • [7] Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis
    Rowe, Christopher C.
    Villemagne, Victor L.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (03) : 377 - +
  • [8] Contribution of the amyloid-PET to diagnosis Alzheimer disease
    Perez Quiros, S.
    Rodriguez Alfonso, B.
    Seijas Marcos, S.
    Sanfiel Delgado, A.
    Mitjavila Casanovas, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S420 - S420
  • [9] Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology
    Silva-Spinola, Anuschka
    Leitao, Maria Joao
    Nadal, Alicia
    Le Bastard, Nathalie
    Santana, Isabel
    Baldeiras, Ines
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [10] Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer’s disease pathology
    Anuschka Silva-Spínola
    Maria João Leitão
    Alicia Nadal
    Nathalie Le Bastard
    Isabel Santana
    Inês Baldeiras
    [J]. Alzheimer's Research & Therapy, 16